Search results
Results from the Health.Zone Content Network
List of largest biomedical companies by market capitalization. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) with current market capitalization of at least US$10 billion, ranked by their market capitalization. It does not include biotechnology companies that ...
C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one. Headquartered in Ingelheim, it operates ...
History Early years. The company's origins go back to a Massachusetts real estate investment trust organized in 1969 as DMG, Inc. In 1978, DMG, Inc. was reorganized as a Florida corporation and changed its name to Diversified Mortgage Investors, Inc. DMG had been invested in retirement home developments when it was taken over by the Rales, and in 1984, the company adopted the name Danaher and ...
DMG-PEG 2000. Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). DMG-PEG 2000 is a synthetic lipid formed by the PEGylation of myristoyl diglyceride. It is used to manufacture lipid nanoparticles that are used in mRNA vaccines, [1] and in particular forms part of the drug delivery ...
Click here for in-depth analysis of the latest health industry news and events impacting stock prices Read the latest financial and business news from Yahoo Finance Show comments
DMG Mori Co., Ltd. (DMG森精機株式会社, DMG Mori Seiki Kabushiki-gaisha) (formerly Mori Seiki Co., Ltd. and DMG Mori Seiki Co., Ltd.) is a Japanese company headquartered in Tokyo and Nara City, engaged primarily in the manufacture and sale of machine tools. [3] [4] [5] Since its establishment, the business has become the largest machine ...
By 2012 the price of a vial of Acthar was $28,400. and was considered to be one of the world's most expensive drugs in 2013. By 2014 the price of Gilead's specialty drug for hepatitis C, Sovaldi or sofosbuvir, was $84,000 to $168,000 for a course of treatment in the U.S., £35,000 in the UK for 12 weeks.
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.